Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects

  • Yee C
  • McElhone K
  • Teh L
 et al. 
  • 3

    Readers

    Mendeley users who have this article in their library.
  • 26

    Citations

    Citations of this article.

Abstract

Outcomes in systemic lupus erythematosus (SLE) can be described in three domains: disease activity, accumulated damage and health-related quality of life (HRQoL). Over the past decade, our understanding and perception of SLE have changed considerably. Gastrointestinal and ophthalmic manifestations have increasingly been recognised, and they are associated with significant morbidity and mortality. Furthermore, it has been realised that there is a deficiency in using generic scales (such as the short form-36 (SF-36)) to assess HRQoL in patients with SLE as they fail to identify issues that are important to patients. As a result, SLE-specific measures of HRQoL have been developed recently. This article looks at the recent updates and changes in the standardised assessment of disease activity and HRQoL in SLE. © 2009 Elsevier Ltd. All rights reserved.

Author-supplied keywords

  • BILAG-2004
  • Health-related quality of life (HRQoL)
  • LupusQoL
  • SLE
  • SLEDAI-2000
  • SLEQoL
  • disease activity
  • outcome measures

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Chee Seng Yee

  • Kathleen McElhone

  • Lee Suan Teh

  • Caroline Gordon

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free